First in human trials of Phyzhon Health PHYRARI FFR-WIRE
Filed with ASX · · 2 pages · English
In the deck
Earlier from Hydrix
- Phyzhon appoints Hydrix as exclusive distributor
- Hydrix raises $10m under institutional placement
- Trading Halt
- Update on AngelMed Guardian implants in Singapore
- Implantation of Next-Generation AngelMed Guardian in US
Later from Hydrix
- 2020 AGM - Executive Chairmans Presentation
- AngelMed receives FDA approval for Guardian upgraded battery
- Investor Presentation - AngelMed Guardian FDA Approval
- Hydrix completes TGA submission for AngelMed Guardian System
- AngelMed completes its first USA commercial Guardian implant
Follow Hydrix into a list and get an email when it puts out news.
Follow Hydrix